Article

Metformin's Effect on Non-Alcoholic Fatty Liver Disease through the miR-200a-5p and AMPK/SERCA2b Pathway

2024-04-19

Abstract excerpt

<title>Abstract</title> <p><bold>Objectives</bold>: Metformin, a primary treatment for type 2 diabetes due to its insulin-sensitizing capabilities, has been widely recognized for its efficacy in improving or mitigating non-alcoholic fatty liver disease (NAFLD). Recent investigations have highlighted the potential involvement of miRNAs in the pathogenesis of NAFLD, yet the precise mechanisms remain elusive. This s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 345a714b-b54f-5d00-a16f-bb2862e9712e
DOI: 10.21203/rs.3.rs-4134752/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metformin's Effect on Non-Alcoholic Fatty Liver Disease through the miR-200a-5p and AMPK/SERCA2b PathwayDOI 10.21203/rs.3.rs-4134752/v1Read

Enpp1 ameliorates NAFLD by regulating hepatocyte lipid metabolism through the AMPK/PPARα signaling pathwaySemantic proximity Read

ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK- PPARα- CPT1A axisSemantic proximity Read

Fenofibrate Alleviates Insulin Resistance and Hepatic Steatosis via Modulation of let-7/ SERCA2b AxisSemantic proximity Read

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read

Regulation of fatty acid oxidation by liraglutide via SIRT1 in hepatocytes: A mechanistic studySemantic proximity Read

<i>Patolakaturohiniyadi Kashayam</i> , exerts anti-steatotic and anti-obesogenic effects via coordinated regulation of lipid metabolism, inflammation, and incretin signallingSemantic proximity Read

PPARα-ERRα crosstalk mitigates metabolic dysfunction-associated steatotic liver disease progressionSemantic proximity Read

Mitophagy as a pivotal axis in non‑alcoholic fatty liver disease: From pathogenic mechanisms to therapeutic strategies (Review)Semantic proximity Read

Shenling Baizhu San Ameliorates Metabolic-Associated Fatty Liver Disease Complicated with Sarcopenia via Regulating AMPKα SignalingSemantic proximity Read

Mammalian Ste20-Like Kinase 1 Regulates AMPK to Mitigate the Progression of Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathwaySemantic proximity Read

Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing <i>PPARA</i>Semantic proximity Read